ArticleJournal for immunotherapy of cancer2020

Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist.

Karin M Knudson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.